Provention bio to report fourth quarter and full year 2022 financial results on march 16, 2023

Red bank, n.j. , feb. 23, 2023 /prnewswire/ -- provention bio, inc. (nasdaq: prvb) (the "company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that it will report its fourth quarter and full year 2022 financial results on thursday, march 16, 2023, before the opening of the u.s. financial markets.

PRVB Ratings Summary

PRVB Quant Ranking